A database of genetic information of more than 270 cancer models, encompassing 25 different childhood cancers, has just been made publicly available. Children’s Cancer Institute contributed 90 leukaemia models to this global effort.
We presented exciting results from preclinical drug testing at a cancer conference this week in the US.
How we got to now in our understanding of MRP1, a protein that ejects chemotherapy drugs from tumour cells and stops them stopping cancer. We're exploring future drugs that target it.
In this second post in our series for Childhood Cancer Awareness month, see how we apply the basics about childhood cancer to search for better treatments.
September is International Childhood Cancer Awareness month. This month on our blog, every Wednesday, see how research gets translated from bench to bedside.
PhD student Ashleigh Fordham tells how her mum's diagnosis with breast cancer was the catalyst for her future career - a scientist curing cancer.
In the second post in a series profiling our emerging researchers, we meet Dr Han Shen who's researching treatments for children with a terrible cancer.
A tiny, heat-loving microbe is at the centre of the genomics revolution. It plays a vital role in the Polymerase Chain Reaction (PCR), a technique that has transformed life sciences research.
In a capital famous for its impressive monuments, last week’s American Association for Cancer Research annual meeting (AACR) was an impressive meeting of minds.
Dr Alvin Kamili is Preclinical Drug Testing Core Team Leader in the Zero Childhood Cancer personalised medicine program. He tells us about his role and the challenges he’s solving in the lead-up to the program’s national clinical trial.